Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
636 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 557 (88%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (29%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-05-28 | 2024-07-02 | 228989 |
| CANDESARTAN | 8MG | TABLET | Actual shortage | 2024-07-03 | 2024-07-04 | 232008 |
| CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-07-03 | 2024-12-02 | 232011 |
| CANDESARTAN | 8MG | TABLET | Actual shortage | 2024-08-01 | 2024-12-02 | 234192 |
| CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-09-09 | 2024-09-10 | 236967 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2019-02-11 | 2019-03-02 | 75262 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2020-03-26 | 2020-04-03 | 109442 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2023-11-22 | 2024-01-17 | 211081 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2024-02-26 | 2024-03-09 | 220663 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2024-04-22 | 2024-08-22 | 225881 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2024-10-21 | 2025-04-02 | 240722 |
| CAPECITABINE | 150MG | TABLET | Resolved | 2024-03-26 | 2025-09-04 | 223358 |
| CAPECITABINE | 500MG | TABLET | Resolved | 2024-03-26 | 2025-09-04 | 223361 |
| CARVEDILOL | 6.25MG | TABLET | Resolved | 2024-01-30 | 2024-02-13 | 217832 |
| CARVEDILOL | 12.5MG | TABLET | Resolved | 2024-04-10 | 2024-04-23 | 224791 |
| CARVEDILOL | 3.125MG | TABLET | Resolved | 2024-09-24 | 2024-11-26 | 238402 |
| CELECOXIB | 100MG | CAPSULE | Resolved | 2018-05-01 | 2021-05-06 | 47801 |
| CELECOXIB | 200MG | CAPSULE | Resolved | 2018-05-01 | 2021-05-06 | 47804 |
| CELECOXIB | 100MG | CAPSULE | Avoided shortage | 2025-01-13 | 2025-02-10 | 247534 |
| CEPHALEXIN | 250MG | TABLET | Resolved | 2023-07-14 | 2024-03-08 | 198742 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |